BioSpace News Archive

Imago BioSciences, Inc. (Imago), a clinical stage biopharmaceutical company developing innovative treatments for myeloid diseases, today announced the appointment of Matthew J. Plunkett, Ph.D., as chief financial officer (CFO)

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin; technology platform for respiratory diseases, cancer, and other indications, today announced that the U.S. Food and Drug Administration (FDA) has lifted the previously announced partial clinical hold on the phase 1 studies of PRS-343.

MJ Biotech, Inc., is pleased to announce that it’s partner Genesis Botanical Research, has secured the location for the first of their CBD extraction facilities.

Orsini Specialty Pharmacy, a leader in rare diseases and gene therapies, announced that it has been selected by Glaukos® Corporation as a specialty pharmacy distribution partner for Photrexa® and Photrexa® Viscous for the treatment of patients with progressive keratoconus and corneal ectasia following refractive surgery See Full Prescribing Information.

NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to shareholders from its Chief Executive Officer, Brian Murphy, providing a year in review and vision for 2021. To Our Shareholders: NanoVibronix is committed to our strategic vision of commercializ

The National Cancer Institute (NCI) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH), exercised their option to enter Phase II of a multi-phase contract to continue physIQ’s development of an AI-based COVID-19 digital biomarker to address the rapid decompensation of high-risk COVID-19 patients.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its Twist Biopharma division has signed two licensing agreements with Serotiny and Applied StemCell.

Developing innovative, minimally invasive medical devices for gastroenterologists, company plans to seek regulatory clearance in the US and reimbursement in European countries

ImmunityBio, Inc., a privately-held immunotherapy company, today announced it has received authorization from the South Africa Health Products Regulatory Authority (SAHPRA) to begin a Phase I clinical trial of its hAd5 T-cell vaccine, the company’s novel COVID-19 vaccine candidate, which will be administered subcutaneously

Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, announced that it has signed agreements with US Dental Depot and IQ Dental Supply for its Wand® Single Tooth Anesthesia System.